Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Vaccines

  Free Subscription


27.10.2025

1 BMJ
1 Clin Infect Dis
1 J Infect
3 J Virol
1 Lancet
1 PLoS One
1 Proc Natl Acad Sci U S A
2 Science
20 Vaccine


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMJ

  1. NUZZO JB
    Defunding mRNA vaccine research leaves us all more vulnerable to future health emergencies.
    BMJ. 2025;391:r2183.
    PubMed        


    Clin Infect Dis

  2. TARTOF SY, Aliabadi N, Goodwin G, Slezak J, et al
    Estimated Vaccine Effectiveness for Respiratory Syncytial Virus-Related Acute Respiratory Illness in Older Adults: Findings From the First Postlicensure Season.
    Clin Infect Dis. 2025 Oct 21:ciaf496. doi: 10.1093.
    PubMed         Abstract available


    J Infect

  3. BORROW R, Caugant DA, Clark SA, Dinleyici EC, et al
    Current global trends in meningococcal disease control, risk groups and vaccination: Consensus of the Global Meningococcal Initiative.
    J Infect. 2025 Oct 17:106635. doi: 10.1016/j.jinf.2025.106635.
    PubMed         Abstract available


    J Virol

  4. DANGI T, Li S, Penaloza-MacMaster P
    Development of a cross-protective common cold coronavirus vaccine.
    J Virol. 2025 Oct 22:e0152625. doi: 10.1128/jvi.01526.
    PubMed         Abstract available

  5. RZYMSKI P, Poniedzialek B, Zarebska-Michaluk D, Tomasiewicz K, et al
    High seroprevalence and high risk: why are older adults more prone to respiratory syncytial virus?
    J Virol. 2025;99:e0143225.
    PubMed         Abstract available

  6. JIAO Z, Li J, Wang P, Yan Y, et al
    Mutations in feline infectious peritonitis virus nonstructural protein 14/16 methyltransferase attenuate the pathogenicity of the virus in cats.
    J Virol. 2025 Sep 9:e0083925. doi: 10.1128/jvi.00839.
    PubMed         Abstract available


    Lancet

  7. JOHANSEN ND, Modin D, Pardo-Seco J, Rodriguez-Tenreiro-Sanchez C, et al
    Effectiveness of high-dose influenza vaccine against hospitalisations in older adults (FLUNITY-HD): an individual-level pooled analysis.
    Lancet. 2025 Oct 17:S0140-6736(25)01742-8. doi: 10.1016/S0140-6736(25)01742.
    PubMed         Abstract available


    PLoS One

  8. NADERIAN R, Ahmad S, Rahmanian M, Aghaamoo S, et al
    Rational design of multi-epitope vaccine for Chandipura virus using an immunoinformatics approach.
    PLoS One. 2025;20:e0335147.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A


  9. Correction to Supporting Information for Milkman et al., A megastudy of text-based nudges encouraging patients to get vaccinated at an upcoming doctor's appointment.
    Proc Natl Acad Sci U S A. 2025;122:e2527439122.
    PubMed        


    Science

  10. CAPLAN A
    Vaccinations for allFair Doses Seth Berkley University of California Press, 2025. 408 pp.
    Science. 2025;390:342.
    PubMed         Abstract available

  11. JACOBS P
    COVID-19 vaccines may boost cancer immunotherapy.
    Science. 2025;390:321-322.
    PubMed         Abstract available


    Vaccine

  12. ASHWINI MA, Gupta S, Lodha L, Ramachandran A, et al
    Immunogenicity of the abbreviated one-week intradermal rabies pre-exposure prophylaxis and its boostability in health-care workers: A retrospective observational cohort study.
    Vaccine. 2025;65:127787.
    PubMed         Abstract available

  13. OPHIR Y, Wong JH, Haddad KR, Huuskonen A, et al
    Expression and characterization of SARS-CoV-2 spike protein in Thermothelomyces heterothallica C1.
    Vaccine. 2025;65:127784.
    PubMed         Abstract available

  14. MATTINGLY TJ 2ND
    Penny wise, pound foolish: The cost of reduced support for measles prevention.
    Vaccine. 2025;65:127830.
    PubMed         Abstract available

  15. CARACO Y, Madar-Balakirski N, Ben-Ami E, Zeltser D, et al
    Using the vesicular stomatitis virus vector (rVSV vector) platform for SARS-CoV-2 vaccine development: Phase 1/2 safety and immunogenicity of IIBR-100 in healthy adults.
    Vaccine. 2025;67:127837.
    PubMed         Abstract available

  16. CIMA MJ, Joshua C, Zohoori N, Porter A 3rd, et al
    Hesitancy towards routine childhood vaccinations before and after the COVID-19 pandemic in Arkansas.
    Vaccine. 2025;66:127834.
    PubMed         Abstract available

  17. LIU B, Huang N, Liu Y, Zhang X, et al
    Parental perceptions and willingness to pay for childhood vaccination experiences in China: a multi-city comprehensive evaluation study.
    Vaccine. 2025;67:127826.
    PubMed         Abstract available

  18. KILLANDER MOLLER I, Hedberg P, Wagner P, Sparen P, et al
    Corrigendum to "Sociodemographic factors influencing SARS-CoV-2 vaccination uptake in people with and without HIV: Insights from a Swedish Nationwide cohort" [Vaccine 62 (2025) 127580].
    Vaccine. 2025;67:127855.
    PubMed        

  19. OIKAWA K, Murakami M, Ochi S, Yamagata M, et al
    Contributing factors to reversed willingness to vaccinate after the COVID-19 pandemic: Insights from a national panel survey.
    Vaccine. 2025;67:127869.
    PubMed         Abstract available

  20. MOHANTY S, Zurovac J, Barna M, Cossrow N, et al
    Corrigendum to "Changes in pneumococcal vaccination disparities by area-level social vulnerability during the COVID-19 pandemic among Medicare and Medicaid enrollees" [Vaccine 62 (2025) 127452].
    Vaccine. 2025;67:127875.
    PubMed        

  21. ANOSIKE C, Ojiakor IM, Etiaba EI, Uguru NP, et al
    Cost-effectiveness and budget impact of malaria, measles, and meningitis vaccines in Africa: a scoping review.
    Vaccine. 2025;67:127853.
    PubMed         Abstract available

  22. MERCADANTE E, Minssen T, Shadlen KC, van Zimmeren E, et al
    A global landscape of patenting activity in COVID-19 vaccines.
    Vaccine. 2025;67:127866.
    PubMed         Abstract available

  23. HAPOSAN JH, Icanervilia AV, Watts E, Widyaningsih SA, et al
    Real-world vaccine effectiveness of typhoid conjugate vaccine in children and adolescents: a systematic review and meta-analysis.
    Vaccine. 2025;67:127872.
    PubMed         Abstract available

  24. MALTEZOU HC, Drositis I, Sourri F, Tseroni M, et al
    Understanding the attitudes of unvaccinated COVID-19 patients hospitalized in Greece toward the 2024-2025 booster COVID-19 vaccine.
    Vaccine. 2025;67:127829.
    PubMed         Abstract available

  25. YAO N, Liu Y, Zhang YY, Wang Q, et al
    Impacts of two-dose mumps-containing vaccine strategy on mumps incidence using segmented regression models.
    Vaccine. 2025;67:127874.
    PubMed         Abstract available

  26. CAO BK, Nguyen TPL, Postma MJ, van der Schans J, et al
    Acceptance and willingness to pay for pneumococcal vaccination in Vietnam: insights into adult preferences and influencing factors.
    Vaccine. 2025;67:127884.
    PubMed         Abstract available

  27. EAGAN RL, Claessens T, Hendrickx G, Larson HJ, et al
    The state of vaccine confidence among the general public in Eastern Europe and Central Asia.
    Vaccine. 2025;67:127849.
    PubMed         Abstract available

  28. BOSETTI P, Peckeu-Abboud L, Andrianasolo RM, Baguelin M, et al
    Modelling the impact of a quadrivalent ACWY meningococcal vaccination and vaccination targeting serogroup B in France.
    Vaccine. 2025;67:127871.
    PubMed         Abstract available

  29. STEINER A, Settgast A, DeSilva M, Payton C, et al
    Tetanus and diphtheria vaccination coverage and electronic health record alerts for immigrants and refugees at three United States health systems, 2017-2023.
    Vaccine. 2025;67:127881.
    PubMed         Abstract available

  30. PORTER A, Cooper S, King A, Presti C, et al
    Regional voices, different choices: Parents' and caregivers' HPV vaccine attitudes in the northeast and Southeast United States.
    Vaccine. 2025;67:127864.
    PubMed         Abstract available

  31. ZHANG X, Li Y, Tian J, Zhang M, et al
    Recombinant truncated gD glycoprotein from E.coli as a thermostable and protective subunit vaccine candidate against ILTV in chickens.
    Vaccine. 2025;67:127882.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.